会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 7. 发明专利
    • DE2258537A1
    • 1973-06-07
    • DE2258537
    • 1972-11-29
    • RHONE POULENC SA
    • MANCY DENISEFLORENT JEANPREUD HOMME JEAN
    • A23K20/195C07G11/00
    • 1381180 Antibiotic 21,190 RP RHONEPOULENC SA 27 Nov 1972 [29 Nov 1971] 54695/72 Heading C2A The novel antibiotic 21,190 RP, having the following characteristics: being a white crystalline powder melting at 226-228‹ C.; soluble in water at pH9 and dimethylformamide, slightly soluble in methanol and ethanol, insoluble in hexane and benzene; containing carbon, hydrogen, oxygen and chlorine with the elementary composition: C=50À5%, H=6À6%, O=38À4%, Cl=4À5%; having an ultra-violet spectrum in 0À1 N.NaOH with an absorption maximum at 292 nm (E 100 1cm =59) and an absorption minimum at 257 nm (E 100 1cm =33) as shown in Fig. 1; an infra-red spectrum (in KBr) as shown in Fig. 2, the main absorption bands being at 3440, 2970, 2930, 2900, 2840, 1735, 1715, 1630, 1570, 1450, 1403, 1380, 1350, 1335, 1305, 1248, 1220, 1192, 1165, 1122, 1090, 1060, 1035, 975, 942, 920, 900, 865, 848, 828, 815, 775, 730, 690, 655, 630, 612, 570, and 548; and showing optical rotation of [α] 20 D =+3‹Œ3‹, [α] 20 436 = + 7‹Œ3‹ and [α] 20 365 = +20Œ3‹ (C=0À5 in 0À1 N.NaOH); is produced by aerobically cultivating Streptomyces hygroscopicus (NRRL 3576) or a mutant thereof capable of producing the antibiotic, in an aqueous nutrient medium and isolating antibiotic 21,190 RP from the medium thus produced. The antibiotic is isolated by extraction from the culture filtrate with a water-immiscible organic solvent (e.g. butanol, methylene chloride, methyl isobutyl ketone or ethyl acetate), concentrating the extract, cooling the concentrate to crystallize the crude antibiotic, dissolving in ethanol and decolorizing with charcoal, concentrating and cooling, and recrystallizing the resulting precipitate from dimethylformamide by adding water. 21,190 RP has antibacterial activity against a broad range of Gram positive and negative bacteria. It may be added to animal feedstuffs or edible carriers to form domestic animal growth promoting compositions or concentrated premixes therefor, and may be admixed with a pharmaceutically acceptable diluent or carrier to provide antibiotic pharmaceutical compositions.
    • 8. 发明专利
    • DE1957980A1
    • 1970-08-13
    • DE1957980
    • 1969-11-18
    • RHONE POULENC SA
    • COURTILLET MANCY GEBFLORENT JEANPREUD HOMME JEAN
    • C12P1/06C07H15/252C12D9/14
    • 1,241,750. Preparing daunorubicin. RHONEPOULENC S.A. 17 Nov., 1969 [18 Nov., 1968], No. 56210/69. Heading C2A. The antibiotic daunorabicin is prepared by aerobically cultivating Streptomyces bifurcus, strain D.S. 23,219, NRRL 3539, or a daunorubicin-producing mutant thereof, on a nutrient medium containing assimilable sources of carbon, nitrogen and inorganic substances, and separating daunorubicin from the culture medium. The preferred culture conditions are pH 6À0 to 7À8 at 23‹ to 33‹ C. The daunorubicin may be separated by extracting the fermentation broth with water-immiscible solvent (e.g. butanol, ethyl acetate or chloroform) at a pH between 5À5 and 9, or preferably by filtering the broth either acidified to pH 1À5 to 2À0 with oxalic acid or admixed with a C 1 -C 3 , aliphatic alcohol and then extracting the filtrate with a water-immiscible solvent. The antibiotic may be recovered by evaporating the solvent or by addition of a non-solvent. The daunorubicin may be converted to its acid-addition salt, e.g. the hydrochloride. Antibiotics 13213 R.P. and 13330 R.P. are also produced in the culture but are not isolated.